| Literature DB >> 27031422 |
David T Broome1, Nabanita S Datta1.
Abstract
In this review, we have highlighted work that has clearly demonstrated that mitogen-activated protein kinase (MAPK) phosphatase-1 (MKP-1), a negative regulator of MAPKs, is an important signaling mediator in bone, muscle, and fat tissue homeostasis and differentiation. Further, we examined recent studies with particular focus on MKP-1 overexpression or deletion and its impact on tissues connected to bone. We also summarized regulation of MKP-1 by known skeletal regulators like parathyroid hormone (PTH)/PTH-related peptide (PTHrP) and bone morphogenic proteins. MKP-1's integration into the pathophysiological state of osteoporosis, osteoarthritis, rheumatoid arthritis, obesity, and muscular dystrophy are examined to emphasize possible involvement of MKP-1 both at the molecular level and in disease complications such as sarcopenia- or diabetes-related osteoporosis. We predict that understanding the mechanism of MKP-1-mediated signaling in bone-muscle-fat crosstalk will be a key in coordinating their activities and developing therapeutics to improve clinical outcomes for diseases associated with advanced age.Entities:
Keywords: Bone; MAPK phosphatase-1; fat; muscle; pathophysiology; signaling
Mesh:
Substances:
Year: 2016 PMID: 27031422 DOI: 10.3109/03008207.2015.1125480
Source DB: PubMed Journal: Connect Tissue Res ISSN: 0300-8207 Impact factor: 3.417